Thursday, 25 October 2018

Reuters Health Report: Trump enacts anti-opioid abuse package in rare bipartisan step

Reuters.com Newsletter

Trump enacts anti-opioid abuse package in rare bipartisan step

Medical treatment will be more widely available to opioid abusers while mailing illicit drugs will be more difficult under a measure to fight drug addiction that was signed into law on Wednesday by U.S. President Donald Trump.

FDA declines to approve pre-filled syringe version of Regeneron's Eylea

Regeneron Pharmaceuticals Inc said on Thursday the U.S. Food and Drug Administration declined to approve a pre-filled syringe version of its blockbuster eye drug Eylea, and has sought additional information regarding its manufacturing and supply processes.

China reports new African swine fever outbreak in Guizhou province

China reported a new African swine fever outbreak in the province of Guizhou on Thursday.

Hearing loss patients at higher risk of hospital readmission

Hard-of-hearing hospital patients who have trouble communicating with medical personnel are more likely to end up back in the hospital within 30 days, compared to patients who don't have trouble hearing, a U.S. study suggests.

Surgeon age doesn't affect cataract surgery outcomes

(Reuters Health) - Late-career surgeons perform a large proportion of cataract operations, and they do it with an overall low rate of adverse events, a Canadian study suggests.

Evidence supports screening for intimate partner violence: task force

(Reuters Health) - Women of reproductive age should be screened for intimate partner violence by their doctors, and physicians should help those who screen positive to get ongoing support services, according to updated recommendations from the U.S. Preventive Services Task Force (USPSTF).

FDA approves first new flu drug in almost two decades

Japan's Shionogi & Co Ltd and Swiss drugmaker Roche won U.S. Food and Drug Administration (FDA) approval for their flu treatment, the first new flu drug approved by the agency in nearly 20 years.

Amgen cuts price of cholesterol drug Repatha by 60 percent

Amgen Inc, looking to boost use of its potent cholesterol drug Repatha, has cut the medication's U.S. list price by 60 percent to $5,850, the U.S. biotechnology company said on Wednesday.

NMC Health, Hassana Investment sign agreement to build Saudi healthcare network

NMC Health said it has signed an agreement with Hassana Investment Company, the investment arm of the General Organization for Social Insurance (GoSI) of Saudi Arabia, to develop a pan Saudi Arabian network of world-class healthcare facilities.

Heart attacks more likely when weather is frigid

(Reuters Health) - Heart attacks occur more often when temperatures plummet, a large new study suggests.

West Africa's Ebola outbreak cost $53 billion - study

An Ebola outbreak that ravaged Sierra Leone, Guinea and Liberia in 2014 cost economies an estimated $53 billion, according to a study in this month's Journal of Infectious Diseases.

Related Videos

Brooklyn witches aim hex at Brett Kavanaugh

Banksy shredding stunt might not have gone to plan

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS